Race and Remdesivir
Examination of Clinical Outcomes in a Racially and Ethnically Diverse Cohort in New York City
Bibliographic Data
COVID-19 has disproportionately burdened communities of color. We observed no difference in median LOS between racial or ethnic groups, which supports the notion that the heterogeneous effect of remdesivir in the literature may be explained in part by underrecruitment or participation of Black, Hispanic, and Asian patients in clinical trials
Cohort · Cumulative incidence · Ethnic group · Incidence (geometry · Residence · Retrospective cohort study · Cardiac Arrest and Resuscitation · Demography · Emergency and Acute Care Studies · Intensive Care Unit Cognitive Disorders · Medicine · Gerontology · Internal Medicine
| Highly cited | No |
|---|